Medical Device Industry News

YONGIN, South Korea--(BUSINESS WIRE)--GC Pharma (006280.KS) today announced that it will support Moderna and the government of the Republic of Korea in the distribution of 40 million doses of COVID-19 Vaccine Moderna, Moderna’s vaccine candidate against COVID-19, to support South Korea’s aim of providing vaccines to the public in a... Read more

PORTLAND, Ore.--(BUSINESS WIRE)--Global biotech executive Dan Snyder, MBA will lead Oregon Bioscience Association's 2021 board. He is joined by science leaders and biotech execs.... Read more

NEW YORK--(BUSINESS WIRE)--The U.S. Food and Drug Administration (FDA) approved Pfizer Inc.’s (NYSE: PFE) supplemental New Drug Application (sNDA) for LORBRENA® (lorlatinib), expanding the indication to include first-line treatment of people with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC). LORBRENA is now indicated for adults with metastatic NSCLC... Read more

BEVERLY HILLS, Calif.--(BUSINESS WIRE)--Patent approved for wearable dialysis device, marking a significant advance in renal (kidney) disease treatment.... Read more

BAY SHORE, N.Y.--(BUSINESS WIRE)--The third effective vaccine in the fight against coronavirus disease 2019 (COVID-19) arrived at several Northwell Health hospitals today, enabling New York State’s largest health system to begin vaccinating hospitalized patients. The first use of the Johnson & Johnson vaccine took place at South Shore University Hospital... Read more

RICHMOND, Va.--(BUSINESS WIRE)-- #fortune500--Owens & Minor Announces Pricing of $500 Million of Senior Notes due 2029... Read more

BELGRADE, Mont.--(BUSINESS WIRE)--Lattice Biologics Ltd. (TSX-V: LBL) (OTCBB: LBLTF) (“Lattice Biologics” or the “Company”) announces that Mr. Donald McInnes has resigned as a director of the Company, effective immediately, so that he can focus his efforts on other professional commitments. Guy Cook, CEO of the Company, commented: “On behalf of... Read more

BRISBANE, Calif.--(BUSINESS WIRE)--Cutera, Inc. (NASDAQ: CUTR), a leading provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced that it intends to offer, subject to market conditions and other factors, $125 million aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private placement... Read more

HUNT VALLEY, Md.--(BUSINESS WIRE)--Omega Healthcare Investors, Inc. (NYSE: OHI) (“Omega”) today announced that it priced an underwritten public offering of $700 million aggregate principal amount of 3.250% Senior Notes due 2033 (the “2033 Notes”). The settlement of this offering is expected to occur on March 10, 2021, subject to customary... Read more

ORANGE, Calif.--(BUSINESS WIRE)--Alignment Healthcare, a mission-based, tech-enabled Medicare Advantage company, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) for a proposed initial public offering of shares of its common stock. The number of shares to be offered and... Read more

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Axcella (Nasdaq:AXLA), a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions, today announced the appointment of Alison D. Schecter, M.D., as the company’s President of Research and Development. In this role, Dr. Schecter will oversee all... Read more

PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Regulatory News: NANOBIOTIX (Paris:NANO) (NASDAQ:NBTX) (Euronext : NANO –– NASDAQ: NBTX – the ‘‘Company’’), a clinical-stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that Laurent Levy, Chief Executive Officer, will speak during a fireside chat at the H.C.... Read more